https://www.selleckchem.com/pr....oducts/bgb-16673.htm
uration of neoadjuvant anthracycline-taxane-based ChT can be reduced in specific patient subgroups without negatively affecting clinical outcomes. To characterize the impact on kidney injury of recurrent urinary tract infections (RUTI) in the frail elderly. Prospective observational study in 200 frail elderly subjects for 1 year. Groups GA ( = 10 subjects without RUTI, GB ( = 10 subjects with RUTI. Variables age, concomitant diseases, glomerular filtration rate (GFR), urine neutrophil gelatinase-associated lipocalin (NGAL) at th
Like
Comment
Share
